FESTUS UZOKWE: Open Payments
NPI 1275532046 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 16 payments from 5 companies in 2025. Trend: 2023 $772 · 2024 $845 · 2025 $590
Food & beverage: $590
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $218 |
| Alkermes, Inc. | 4 | $162 |
| Janssen Pharmaceuticals, Inc | 4 | $125 |
| Otsuka America Pharmaceutical, Inc. | 2 | $58 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
Products named: UZEDY, LYBALVI, INVEGA SUSTENNA, ABILIFY MAINTENA, ARISTADA, INVEGA, COBENFY, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
